Abstract: The present invention relates to a metal-organic framework and an energy storage system having the same, and more specifically, to an energy storage system that is capable of providing excellent electrical conductivity and electrochemical capacity properties, especially excellent electrochemical performance at low temperatures, by means of a novel one-dimensional metal-organic framework having thianthrene-based organic ligands.

Abstract: The present invention relates to a metal-organic framework and an energy storage system having the same, and more specifically, to an energy storage system that is capable of providing excellent electrical conductivity and electrochemical capacity properties, especially excellent electrochemical performance at low temperatures, by means of a novel one-dimensional metal-organic framework having thianthrene-based organic ligands.

Abstract: The present disclosure relates to tetrapodal zinc-oxide nanostructures (T-ZONS), microneedle devices, and methods for treating or preventing a zoonotic herpesvirus infection.

Abstract: A cloud-connected ring-based sensor system includes a ring, a ring-manager application (e.g., running on a mobile device), and cloud services. The ring collects sensor data and forwards it to the app, which forwards it (modified or unmodified) to the cloud services. The cloud services can analyze the data, e.g., to look for trends. The cloud services can provide access to the data and analysis results to a provider, who can then return information (instructions, advice, etc.) to the cloud services, which makes the information available to the ring-wearer via the ring-manager application. The sensor can be a heartbeat sensor. In that case, the ring automatically switches between an active mode and a standby mode depending on whether or not a heartbeat is detected.

Abstract: Systems and methods are described herein are directed to determining optimal operating set points in sync with dynamic demand responsive to time-varying events in a data center. The method includes establishing, by a matrix module executing on a computing device, a data matrix of a first set of critical data based on resources in the data center representing dynamic demand, the dynamic demand responsive to the time-varying events in the data center. A decomposition module can generate new critical data based in part on the first set of critical data. A prediction module can determine optimal operating set points using the new critical data. The optimal operating set points for the resources can be transmitted by a communications module to a data center orchestration unit such as a building management module.

Abstract: Systems and methods are described herein are directed to determining optimal operating set points in sync with dynamic demand responsive to time-varying events in a data center. The method includes establishing, by a matrix module executing on a computing device, a data matrix of a first set of critical data based on resources in the data center representing dynamic demand, the dynamic demand responsive to the time-varying events in the data center. A decomposition module can generate new critical data based in part on the first set of critical data. A prediction module can determine optimal operating set points using the new critical data. The optimal operating set points for the resources can be transmitted by a communications module to a data center orchestration unit such as a building management module.

Abstract: Specific applications of particles and particle agglomerates with semiconductor surfaces are provided. The particles and particle agglomerates display a high affinity for viral particles, and may be used therapeutically and/or prophylactically to treat or prevent viral infections. The particles and particle agglomerates may also be used to remove viral particles from a surface or fluid, e.g., as an absorbent in a filter, applied to surfaces to render them virostatic, and as tool to handle viral particles, e.g., for research, diagnostic, or decontamination purposes.

Abstract: Specific applications of particles and particle agglomerates with semiconductor surfaces are provided. The particles and particle agglomerates display a high affinity for viral particles, and may be used therapeutically and/or prophylactically to treat or prevent viral infections. The particles and particle agglomerates may also be used to remove viral particles from a surface or fluid, e.g., as an absorbent in a filter, applied to surfaces to render them virostatic, and as tool to handle viral particles, e.g., for research, diagnostic, or decontamination purposes.

Abstract: Described herein is a process for the removal of sulfones by mesoporous silica adsorbents having narrow pore size distribution which could be controlled to specification for the selective removal of sulfones from oxidized hydrocarbon fuels wherein the sulfones were present due to oxidative conversion of organo-sulfur compounds by a suitable oxidizing solution. The mesoporous adsorbents showed typically 2-18 times higher equilibrium loading capacity for sulfones in comparison to the commercially available adsorbents.

Abstract: The present invention provides a novel sensor for the estimation of total cholesterol in human blood serum using molecular imprint of cholesterol. Human blood serum contains 150-250 mg/dl cholesterol. The present invention provides a sensor device and a process for the fabrication of ISFET (Ion Selective Field Effect Transister) coated with molecular imprint of cholesterol on the SiO2+Si3N4 dielectric gate of the said electrode. The molecular imprint of cholesterol (MIPC) anchored in to a silica matrix sensing material is identified as a sensing material which has specific selectivity towards the cholesterol in presence of other organic constituents in human blood serum.

Abstract: Disclosed herein is a process for the preparing (S)-3-(aminomethyl)-5-methylhexanoic acid by optical resolution of (±)-3-(aminomethyl)-5-methylhexanoic acid and a resolving agent employing a suitable solvent.

Abstract: Described herein is a process for the removal of sulfones by mesoporous silica adsorbents having narrow pore size distribution which could be controlled to specification for the selective removal of sulfones from oxidised hydrocarbon fuels wherein the sulfones were present due to oxidative conversion of organo-sulfur compounds by a suitable oxidizing solution. The mesoporous adsorbents showed typically 2-18 times higher equilibrium loading capacity for sulfones in comparison to the commercially available adsorbents.

Abstract: The present invention relates to the development of a biosensor to determine potassium in human blood serum using dibenzo-18-crown-6 (DB18C6) as ionophore. Human blood serum contains potassium in ppm levels i.e 137 to 200 mg/litre and sodium co exists with a 30 times higher concentration. Such a high concentration tends to interfere the selectivity towards potassium, but DB18C6 proves to have an excellent selectivity towards potassium and is highly sensitive to the lowest concentration of potassium levels present in the human blood serum. So the present invention reports the fabrication and characterization of ISFET (Ion Selective Field Effect transistor) coated with a monolayer of crown ether, dissolved in chloroform, on the gate of electrode.

Abstract: The present invention provides a novel sensor for the estimation of total cholesterol in human blood serum using molecular imprint of cholesterol. Human blood serum contains 150-250 mg/dl cholesterol. The present invention provides a sensor device and a process for the fabrication of ISFET (Ion Selective Field Effect Transister) coated with molecular imprint of cholesterol on the SiO2+Si3N4 dielectric gate of the said electrode. The molecular imprint of cholesterol (MIPC) anchored in to a silica matrix sensing material is identified as a sensing material which has specific selectivity towards the cholesterol in presence of other organic constituents in human blood serum.

Abstract: A novel method for preparing a compound of formula I which comprises of coupling the piperazine derivative of formula II with alkyl halide containing compound of the formula III by heating in solvent free conditions or, optionally, in a minimum quantity of non-aqueous suspending liquid, in presence of a catalyst and a neutralizing agent to neutralize the hydrohalic acid.

Abstract: A process for the preparation of compounds of Formula I and their pharmaceutically acceptable acid addition salt wherein, R1 is phenyl or substituted phenyl R2 is selected from a group consisting of phenyl which is unsubstituted or substituted with 1 or 2 substituents, each independently selected from Cl, F, or pyridine, or naphthalene, or NHCOR4 wherein R4 is aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclyl. R3 is selected from a group of formula wherein R5 is phenyl which is unsubstituted or substituted with 1 or 2 substituents each independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, nitro, amino, haloalkyl, haloalkoxy etc.

Abstract: The invention provides a novel herbal formulation used to improve the memory and in treatment of senile and presenile dementia as a brain tonic. Formulation(s) comprises of alcoholic extract of Tinospora cordifolia, Centella asiatica, Withania somnifera, Mucuna pruriens and Curcuma longa. The formulation can be used as an emulsion or as a soft gelatin capsule for oral dosage forms.